Consumption of Chocolate in Pregnant Women.
CHOCENTA
1 other identifier
interventional
160
1 country
1
Brief Summary
The purpose of this study is to investigate the acute and chronic effect of consumption of flavanol-rich chocolate on endothelium function in pregnant women at high risk for preeclampsia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started May 2011
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 2, 2011
CompletedFirst Posted
Study publicly available on registry
September 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedApril 9, 2015
April 1, 2015
3.3 years
May 2, 2011
April 8, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in endothelial function
within the first 12 weeks of chocolate intake
Secondary Outcomes (4)
Doppler of uterine arteries
within the first 12 weeks of chocolate intake
Blood pressure
within the first 12 weeks of chocolate intake
Plasma biomarker of endothelium function
within the first 12 weeks of chocolate intake
Plasma biomarker of chocolate intake
within the first 12 weeks of chocolate intake
Study Arms (2)
Dark chocolate
EXPERIMENTALPlacebo chocolate
PLACEBO COMPARATORPlacebo intervention
Interventions
The aim of this study is to evaluate the beneficial effect of dark chocolate consumption through the activity of flavanols on the endothelial function and blood pressure regulation, in acute (after 3 hours) and chronic effect (12 weeks), among pregnant women at high risk for preeclampsia.
Placebo intervention
Eligibility Criteria
You may qualify if:
- Pregnant women between the ages of 18 and 40 years.
- Presence of uterine diastolic notches measured by uterine artery Doppler between 10 and 14 weeks.
You may not qualify if:
- Hypertension requiring medication.
- Currently or previously use of medications interfering with glucose or lipids metabolism.
- Use of supplements or natural health products that interfere with blood pressure.
- Consumption of 1 or more alcohol drink per day.
- Allergy or intolerance to nuts or chocolate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
Study Sites (1)
Laval University, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels.
Québec, Quebec, G1V 0A6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvie Dodin, MD
Laval University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2011
First Posted
September 9, 2011
Study Start
May 1, 2011
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
April 9, 2015
Record last verified: 2015-04